Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $608.92 Consensus Price Target from Brokerages

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have earned an average recommendation of “Moderate Buy” from the twenty-nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation, nineteen have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $608.9231.

A number of equities analysts have commented on the stock. Robert W. Baird set a $655.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. HSBC lifted their price target on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Finally, Evercore ISI lifted their target price on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $574.23 on Friday. The company has a market cap of $205.85 billion, a price-to-earnings ratio of 75.96, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical has a 1 year low of $425.00 and a 1 year high of $616.00. The stock’s 50 day simple moving average is $503.24 and its two-hundred day simple moving average is $505.38.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.84 EPS. As a group, analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 7,562 shares of the stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $193,595.79. This represents a 95.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This trade represents a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 86,804 shares of company stock valued at $48,043,866 over the last three months. Corporate insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Tobam lifted its stake in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares during the last quarter. Kilter Group LLC purchased a new stake in Intuitive Surgical in the second quarter worth $27,000. Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth $30,000. TD Capital Management LLC boosted its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the period. Finally, Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical in the third quarter worth about $27,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.